Performance analysis of Protara Therapeutics (TARA)
Annual Return
Over the past 3 years, TARA has had an average annual return of +13.58%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, TARA has had an average annual return of -14.28%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, TARA has had an average annual return of -35.42%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Oct 22, 2014, TARA has had an average annual return of -32.37%, underperforming the benchmark SPY, which returned +14.06% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -24.06% | +0.76% | +180.85% | -29.85% | -60.12% | -72.14% | +47.43% | -81.93% | +19.48% | -0% | -87.75% | +49.14% |
| 2014 | |||||||||||
| +3.69% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +32.33% | -9.66% | -18.24% | +2.31% | -12.78% | -18.10% | +6.32% | -24.06% | |||||
| 2025 | -6.82% | -24.39% | +13.98% | -17.92% | -12.64% | -0% | +1.32% | +1.30% | +38.46% | +19.44% | +42.64% | -27.72% | +0.76% |
| 2024 | +36.17% | +78.13% | -12.28% | -26.00% | -5.41% | -25.71% | +7.69% | -10.71% | -8.00% | +36.96% | +19.05% | +76% | +180.85% |
| 2023 | +20.90% | +8.64% | -11.36% | +1.28% | -11.39% | -14.29% | +8.33% | -16.92% | -22.22% | -26.19% | +16.13% | +30.56% | -29.85% |
| 2022 | -22.62% | -11.54% | +10.43% | -28.35% | -8.79% | -12.05% | +2.74% | +14.67% | -13.95% | +4.05% | +14.29% | -23.86% | -60.12% |
| 2021 | -25.70% | -4.24% | -8.62% | -28.83% | -15.41% | +2.97% | -18.52% | +5.56% | -17.70% | -0% | -0% | -2.33% | -72.14% |
| 2020 | +98.04% | -12.35% | -19.30% | +6.63% | +121.93% | -46.09% | -14.91% | -14.31% | -21.39% | +6.68% | +34% | +0.67% | +47.43% |
| 2019 | +18.96% | +7.76% | -82.73% | -18.36% | +2.44% | -0.95% | -11.08% | -13.55% | -18.81% | -3.86% | +20.08% | +36.79% | -81.93% |
| 2018 | +18.43% | +0% | +11.15% | -14.00% | +0% | +13.95% | -12.24% | +9.28% | -17.03% | -17.95% | +3.76% | +36.74% | +19.48% |
| 2017 | +2.64% | -5.14% | -5.37% | -17.13% | -17.29% | +27.09% | -11.45% | -3.71% | +53.86% | -9.98% | -2.79% | +8.54% | -0% |
Drawdown analysis of Protara Therapeutics (TARA)
The maximum drawdown for the TARA was -99.86%, occurring on Nov 21, 2023. This drawdown has not yet recovered.
The current TARA drawdown is -99.49%.
Since Oct 22, 2014 TARA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.86% | Jul 17, 2015 | 2102 | Nov 21, 2023 | Ongoing | Ongoing | Ongoing |
| -28.79% | Apr 14, 2015 | 9 | Apr 27, 2015 | 9 | May 8, 2015 | 18 |
| -17.57% | Nov 26, 2014 | 6 | Dec 5, 2014 | 20 | Jan 6, 2015 | 26 |
| -17.36% | May 8, 2015 | 4 | May 14, 2015 | 4 | May 20, 2015 | 8 |
| -15.95% | Jan 13, 2015 | 33 | Mar 3, 2015 | 23 | Apr 6, 2015 | 56 |
| -13.81% | Jul 1, 2015 | 5 | Jul 9, 2015 | 5 | Jul 16, 2015 | 10 |
| -10.24% | May 20, 2015 | 3 | May 26, 2015 | 5 | Jun 2, 2015 | 8 |
| -8.39% | Jun 3, 2015 | 14 | Jun 23, 2015 | 5 | Jun 30, 2015 | 19 |
| -6.67% | Apr 6, 2015 | 1 | Apr 7, 2015 | 1 | Apr 8, 2015 | 2 |
| -2.44% | Nov 4, 2014 | 7 | Nov 13, 2014 | 2 | Nov 17, 2014 | 9 |
| -1.36% | Nov 17, 2014 | 3 | Nov 20, 2014 | 2 | Nov 24, 2014 | 5 |
| -0.38% | Nov 24, 2014 | 1 | Nov 25, 2014 | 1 | Nov 26, 2014 | 2 |
| -0.38% | Jan 6, 2015 | 1 | Jan 7, 2015 | 2 | Jan 9, 2015 | 3 |
| -0.30% | Oct 22, 2014 | 1 | Oct 23, 2014 | 7 | Nov 3, 2014 | 8 |